[
  {
    "ts": null,
    "headline": "Cardinal Health Inc. stock rises Monday, still underperforms market",
    "summary": "Cardinal Health Inc. stock rises Monday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=9e915d92fbf9b98737e07c750d4f4c857214c8f1b173759d4ec3ad1bde7e062c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742835360,
      "headline": "Cardinal Health Inc. stock rises Monday, still underperforms market",
      "id": 133399859,
      "image": "",
      "related": "CAH",
      "source": "MarketWatch",
      "summary": "Cardinal Health Inc. stock rises Monday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=9e915d92fbf9b98737e07c750d4f4c857214c8f1b173759d4ec3ad1bde7e062c"
    }
  },
  {
    "ts": null,
    "headline": "GEHC Stock Falls Despite New Launch to Boost Breast Cancer Diagnosis",
    "summary": "GE HealthCare aims to deliver optimal outcomes with its innovative, patient-friendly and efficient AI-driven technology via its latest product offering.",
    "url": "https://finnhub.io/api/news?id=d9b56b81dce4bc9c8416dc369caa9c502b6d94bac00eaf92ef13e47dabf81de0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742827620,
      "headline": "GEHC Stock Falls Despite New Launch to Boost Breast Cancer Diagnosis",
      "id": 133349529,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "GE HealthCare aims to deliver optimal outcomes with its innovative, patient-friendly and efficient AI-driven technology via its latest product offering.",
      "url": "https://finnhub.io/api/news?id=d9b56b81dce4bc9c8416dc369caa9c502b6d94bac00eaf92ef13e47dabf81de0"
    }
  },
  {
    "ts": null,
    "headline": "BDX Shares May Climb as GalaFLEX LITE Trial Hits Key Milestone",
    "summary": "BD advances its clinical trial for the bioabsorbable GalaFLEX LITE scaffold, aiming to improve outcomes in breast implant revision surgeries and patient recovery.",
    "url": "https://finnhub.io/api/news?id=7e027c395cbe12098a9453f7a53bda9eeb4815725fd37c95cdecc4da3035c611",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742826060,
      "headline": "BDX Shares May Climb as GalaFLEX LITE Trial Hits Key Milestone",
      "id": 133349531,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "BD advances its clinical trial for the bioabsorbable GalaFLEX LITE scaffold, aiming to improve outcomes in breast implant revision surgeries and patient recovery.",
      "url": "https://finnhub.io/api/news?id=7e027c395cbe12098a9453f7a53bda9eeb4815725fd37c95cdecc4da3035c611"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Hold GEHC Stock in Your Portfolio for Now",
    "summary": "GE HealthCare's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.",
    "url": "https://finnhub.io/api/news?id=842fa6a7deac2892315070577528d44397f2567bf5c3bc79c7ca62365e04cedb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742825520,
      "headline": "Here's Why You Should Hold GEHC Stock in Your Portfolio for Now",
      "id": 133349532,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "GE HealthCare's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.",
      "url": "https://finnhub.io/api/news?id=842fa6a7deac2892315070577528d44397f2567bf5c3bc79c7ca62365e04cedb"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health: Not Expensive, But Still Rather A 'Hold'",
    "summary": "Cardinal Health's stock has surged 133% since May 2022, but its long-term chart reveals a history of prolonged correction. Read my analysis of CAH stock.",
    "url": "https://finnhub.io/api/news?id=d11a236402589517a5a932d3bae7a49f1c57abefc1626bad065cc0b6fda88eec",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742803473,
      "headline": "Cardinal Health: Not Expensive, But Still Rather A 'Hold'",
      "id": 133336853,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/511098058/image_511098058.jpg?io=getty-c-w1536",
      "related": "CAH",
      "source": "SeekingAlpha",
      "summary": "Cardinal Health's stock has surged 133% since May 2022, but its long-term chart reveals a history of prolonged correction. Read my analysis of CAH stock.",
      "url": "https://finnhub.io/api/news?id=d11a236402589517a5a932d3bae7a49f1c57abefc1626bad065cc0b6fda88eec"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health: A Safe Bet On U.S. Healthcare But Valuations Aren't Enticing",
    "summary": "Cardinal Health outpaces S&P 500 with strong growth in specialty pharmaceuticals. Read why CAH stock has limited upside potential.",
    "url": "https://finnhub.io/api/news?id=1bd24541b2ea4405da6a0c686247355b1ca28e7d88f2f7049f1181d38987870b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742777801,
      "headline": "Cardinal Health: A Safe Bet On U.S. Healthcare But Valuations Aren't Enticing",
      "id": 133333982,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2046288144/image_2046288144.jpg?io=getty-c-w1536",
      "related": "CAH",
      "source": "SeekingAlpha",
      "summary": "Cardinal Health outpaces S&P 500 with strong growth in specialty pharmaceuticals. Read why CAH stock has limited upside potential.",
      "url": "https://finnhub.io/api/news?id=1bd24541b2ea4405da6a0c686247355b1ca28e7d88f2f7049f1181d38987870b"
    }
  }
]